Biosino Bio-Technology & Science Inc. (8247.HK) Stock Competitors & Peer Comparison

8247.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 8247.HK stands at 192.2M. In comparison, 2359.HK has a market cap of 440.3B. Regarding current trading prices, 8247.HK is priced at HK$2.99, while 2359.HK trades at HK$153.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

8247.HK currently has a P/E ratio of -7.29, whereas 2359.HK's P/E ratio is 19.49. In terms of profitability, 8247.HK's ROE is N/A, compared to 2359.HK's ROE of +0.27%. Regarding short-term risk, 8247.HK is less volatile compared to 2359.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 8247.HK.Check 2359.HK's competition here

8247.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 8247.HK stands at 192.2M. In comparison, 2268.HK has a market cap of 67.4B. Regarding current trading prices, 8247.HK is priced at HK$2.99, while 2268.HK trades at HK$53.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

8247.HK currently has a P/E ratio of -7.29, whereas 2268.HK's P/E ratio is 42.71. In terms of profitability, 8247.HK's ROE is N/A, compared to 2268.HK's ROE of +0.16%. Regarding short-term risk, 8247.HK is less volatile compared to 2268.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 8247.HK.Check 2268.HK's competition here

8247.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 8247.HK stands at 192.2M. In comparison, 6127.HK has a market cap of 32.5B. Regarding current trading prices, 8247.HK is priced at HK$2.99, while 6127.HK trades at HK$23.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

8247.HK currently has a P/E ratio of -7.29, whereas 6127.HK's P/E ratio is 31.32. In terms of profitability, 8247.HK's ROE is N/A, compared to 6127.HK's ROE of +0.06%. Regarding short-term risk, 8247.HK is less volatile compared to 6127.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 8247.HK.Check 6127.HK's competition here

8247.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 8247.HK stands at 192.2M. In comparison, 9860.HK has a market cap of 2.8B. Regarding current trading prices, 8247.HK is priced at HK$2.99, while 9860.HK trades at HK$3.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

8247.HK currently has a P/E ratio of -7.29, whereas 9860.HK's P/E ratio is 89.44. In terms of profitability, 8247.HK's ROE is N/A, compared to 9860.HK's ROE of N/A. Regarding short-term risk, 8247.HK is more volatile compared to 9860.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 8247.HK.Check 9860.HK's competition here

8247.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 8247.HK stands at 192.2M. In comparison, 2251.HK has a market cap of 1B. Regarding current trading prices, 8247.HK is priced at HK$2.99, while 2251.HK trades at HK$10.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

8247.HK currently has a P/E ratio of -7.29, whereas 2251.HK's P/E ratio is -5.60. In terms of profitability, 8247.HK's ROE is N/A, compared to 2251.HK's ROE of -0.02%. Regarding short-term risk, 8247.HK is more volatile compared to 2251.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 8247.HK.Check 2251.HK's competition here

8247.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 8247.HK stands at 192.2M. In comparison, 8037.HK has a market cap of 634.2M. Regarding current trading prices, 8247.HK is priced at HK$2.99, while 8037.HK trades at HK$0.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

8247.HK currently has a P/E ratio of -7.29, whereas 8037.HK's P/E ratio is -3.18. In terms of profitability, 8247.HK's ROE is N/A, compared to 8037.HK's ROE of -0.31%. Regarding short-term risk, 8247.HK is less volatile compared to 8037.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 8247.HK.Check 8037.HK's competition here

8247.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 8247.HK stands at 192.2M. In comparison, 2325.HK has a market cap of 368.8M. Regarding current trading prices, 8247.HK is priced at HK$2.99, while 2325.HK trades at HK$0.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

8247.HK currently has a P/E ratio of -7.29, whereas 2325.HK's P/E ratio is -1.36. In terms of profitability, 8247.HK's ROE is N/A, compared to 2325.HK's ROE of +0.00%. Regarding short-term risk, 8247.HK is less volatile compared to 2325.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 8247.HK.Check 2325.HK's competition here

8247.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 8247.HK stands at 192.2M. In comparison, 0928.HK has a market cap of 120.3M. Regarding current trading prices, 8247.HK is priced at HK$2.99, while 0928.HK trades at HK$0.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

8247.HK currently has a P/E ratio of -7.29, whereas 0928.HK's P/E ratio is 8.39. In terms of profitability, 8247.HK's ROE is N/A, compared to 0928.HK's ROE of +0.01%. Regarding short-term risk, 8247.HK is more volatile compared to 0928.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 8247.HK.Check 0928.HK's competition here